Clinical Trial

Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points: 1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).
Trial Details
NCT Number NCT07275125
Lead Sponsor Sohag University
Conditions Drug Resistant Epilepsy
Enrollment 40 participants
Start Date 2025-12-30
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-10